Syndicated Reports: Premier Competitive Intelligence Benchmarking
PharmaForce’s syndicated reports explore the top commercial organizational strategies across critical therapy areas. These reports deliver detailed data insights essential for making informed, timely decisions.
Comprehensive Suite of Market + Operational Insight Tools and Analysis
Strategic Approaches
Provides an overview of the therapy area market at the time of research, detailing each profiled company’s commercial operational strategies, call reach, and frequency analysis.
Organizational Structures
Explore the organizational structures and reporting relationships of key commercial personnel including sales, marketing, field medical, and market access within each profiled company.
Product Portfolio Management
Learn about company product portfolios and how they prioritize the promotion of brands among key physician audiences.
Detailing Intensity Analysis
This analysis covers the annualized number of details each profiled sales force conducts with their target physician audiences.
Compensation
Includes the average annual salary and bonuses for the sales-related personnel of each profiled company.
Competitive Benchmarking of Key Therapeutic Areas’ Sales and Organizational Approaches Globally
Oncology Syndicated Benchmarking Reports
Updated annually for over 20 years, these syndicated reports benchmark the commercial strategies of leading oncology/hematology sales and marketing organizations in the United States and Europe.
Historical Oncology reports are also available for Japan and Latin America.
Immunology Syndicated Benchmarking Reports
These syndicated Immunology reports are updated annually and benchmark the commercial strategies of leading dermatology, gastroenterology, and rheumatology sales and marketing organizations in the United States and Europe.
Historical Immunology reports are also available for Japan.
Additional Therapy Areas
Cardiovascular & Metabolic Syndicated Benchmarking Reports
These reports benchmark the commercial strategies of leading cardiovascular, diabetes, and obesity sales and marketing organizations in the United States and Europe. The 2025 editions will become available in Q4.
Liver & Infectious Disease Syndicated Benchmarking Reports
These reports benchmark the commercial strategies of leading liver & infectious disease sales and marketing organizations in the United States. The 2025 edition is the most recent available.
Central Nervous System Syndicated Benchmarking Reports
These reports benchmark the commercial strategies of leading CNS sales and marketing organizations in the United States and Europe. The 2024 editions are the most recent available.
Historical CNS reports are also available for the areas of Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, and Migraine.
Ophthalmology Syndicated Benchmarking Reports
These reports benchmark the commercial strategies of leading ophthalmology sales and marketing organizations in the United States and Europe. The 2024 editions are the most recent available.
Further Report Coverage
Can’t find what you are looking for? PharmaForce offers a range of historical benchmarking reports in areas like Hemophilia and Biosimilars.
Beyond therapy areas, we provide benchmarking on strategic areas such as Medical Liaisons, Market Access, Reimbursement, and Digital Marketing.
Additionally, we welcome custom benchmarking projects at the request of our clients!